financetom
Business
financetom
/
Business
/
Huntington Ingalls tops quarterly results as shipbuilding snags ease
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Huntington Ingalls tops quarterly results as shipbuilding snags ease
Jul 31, 2025 6:26 AM

(Reuters) -U.S. military shipbuilder Huntington Ingalls reported second-quarter results above Wall Street estimates on Thursday, as production issues ease at its shipyards and demand booms for submarines.

The company's shares rose about 5% in premarket trading.

Huntington is a prime contactor for the U.S. Navy's nuclear-powered Columbia-class submarines and makes Virginia-class submarines at its Newport News Shipbuilding facility.

Huntington's output has suffered in recent quarters due to persistent problems in retaining skilled shipyard labor, despite China's expanding naval footprint and high global tensions keeping demand for submarines and aircraft carriers high.

"We have seen early signs that targeted investments are helping to stabilize the workforce and supply chain, in support of the broader maritime industrial base," CEO Chris Kastner said in a statement.

U.S. President Donald Trump's push to revitalize American shipbuilding to deter China is also expected to boost sales for companies like Huntington.

It posted a second quarter per-share profit of $3.86, surpassing analysts' average estimate of $3.28, according to data compiled by LSEG.

Its sales and services revenue rose 3.5% to $3.08 billion in the quarter, also topping expectations of $2.93 billion.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Top Premarket Decliners
Top Premarket Decliners
Aug 28, 2025
07:57 AM EDT, 08/28/2025 (MT Newswires) -- Cel-Sci ( CVM ) shares were 31% lower pre-bell Thursday after the company said late Wednesday that it priced a public offering of about 1.1 million common shares at $9 apiece for gross proceeds of about $10 million. Apollomics ( APLM ) stock was down 21% following a 2.9% gain in the previous...
Palisades Goldcorp on Board and Management Changes
Palisades Goldcorp on Board and Management Changes
Aug 28, 2025
07:57 AM EDT, 08/28/2025 (MT Newswires) -- Palisades Goldcorp ( PLGDF ) on Thursday said shareholders approved the re-election of Gregor Gregersen and Elizabeth Harrison to its board at its meeting held on Wednesday. Effective immediately, Philip O'Neill will serve as its chief operating officer. Collin Kettell and Philip O'Neill were also elected to the board. The company said that...
China's major airlines stay in red in first half on oversupply, low fares
China's major airlines stay in red in first half on oversupply, low fares
Aug 28, 2025
BEIJING/SEOUL (Reuters) -China's two largest airlines narrowed their first-half losses but remained firmly in the red as a capacity surplus kept fares low, earnings reports released on Thursday showed, underscoring the fragility of the sector's post-pandemic recovery. Flagship carrier Air China reported a net loss of 1.8 billion yuan ($252 million) for the six months to June, 35% lower than...
Aldeyra Therapeutics Says EMA Grants Orphan Drug Designation for Eye Disease Drug
Aldeyra Therapeutics Says EMA Grants Orphan Drug Designation for Eye Disease Drug
Aug 28, 2025
07:52 AM EDT, 08/28/2025 (MT Newswires) -- Aldeyra Therapeutics ( ALDX ) said Thursday that the European Medicines Agency has granted orphan drug designation to its experimental treatment, ADX-2191, for treating rare types of eye diseases. The company said it plans to begin a clinical trial in the second half of 2025 under a Special Protocol Assessment agreement with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved